HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells

被引：0
|
作者：
J. R. Ribeiro
C. Schorl
N. Yano
N. Romano
K. K. Kim
R. K. Singh
R. G. Moore
机构：
[1] Women and Infants Hospital,Center for Genomics and Proteomics, Genomics Core Facility
[2] Department of Obstetrics and Gynecology,Wilmot Cancer Institute, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology
[3] Program in Women’s Oncology,undefined
[4] Molecular Therapeutics Laboratory,undefined
[5] Brown University,undefined
[6] University of Rochester Medical Center,undefined
来源：
Journal of Ovarian Research | / 9卷
关键词：
HE4; Epithelial ovarian cancer; Chemoresistance; Paclitaxel resistance; Platinum resistance; MAPK signaling; Tubulin; EGR1; SKOV3 cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells
    Ribeiro, J. R.
    Schorl, C.
    Yano, N.
    Romano, N.
    Kim, K. K.
    Singh, R. K.
    Moore, R. G.
    JOURNAL OF OVARIAN RESEARCH, 2016, 9
  • [2] HE4 overexpression promotes chemoresistance in ovarian cancer cells
    Singh, R.
    Horan, T.
    Yano, N.
    Kim, K.
    Lange, T.
    Lambert-Messerlian, G.
    Moore, R.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S136 - S136
  • [3] EVALUATION OF HE4 IN OVARIAN CANCER
    Nakajima, T.
    Nagaishi, M.
    Maebayashi, A.
    Miyakawa, Y.
    Ikeda, Y.
    Sato, M.
    Kawana, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 785 - 785
  • [4] Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells
    Wang, Huan
    Zhu, Liancheng
    Gao, Jian
    Hu, Zhenhua
    Lin, Bei
    ONCOLOGY REPORTS, 2015, 33 (01) : 403 - 412
  • [5] HE4 - A novel biomarker for ovarian cancer
    Verch, Thorsten
    Glover, Curtis L.
    Beyer, Heather L.
    Tran, Ly
    Geschwindt, Ryan D.
    Hellstrom, Ingegerd
    Hellstrom, Karl-Erik
    Sardesai, Niranjan Y.
    Allard, W. Jeffrey
    TUMOR BIOLOGY, 2007, 28 : 108 - 108
  • [6] HE4 and other markers in ovarian cancer
    Kucera, R.
    Topolcan, O.
    Svobodova, S.
    Presl, J.
    Fuchsova, R.
    Vrzalova, J.
    Rokyta, Z.
    Betincova, L.
    Novotny, Z.
    17TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI), 2013, : 173 - 175
  • [7] HE4: really a novel biomarker for ovarian cancer?
    Yucel, E.
    Ilter, E.
    Aksungar, F. B.
    Celik, A.
    Peker, B. H.
    Serifsoy, E.
    Bozkurt, S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (01) : 59 - 64
  • [8] Diagnostic and Prognostic Potential of HE4 in Ovarian Cancer
    Langhe, R.
    O'Toole, S.
    Norris, L.
    Petzold, M.
    Harrison, A.
    Varley, R.
    Abusaadeh, F.
    Gleeson, N.
    O'Leary, J.
    MODERN PATHOLOGY, 2013, 26 : 284A - 284A
  • [9] Diagnostic and Prognostic Potential of HE4 in Ovarian Cancer
    Langhe, R.
    O'Toole, S.
    Norris, L.
    Petzold, M.
    Harrison, A.
    Varley, R.
    Abusaadeh, F.
    Gleeson, N.
    O'Leary, J.
    LABORATORY INVESTIGATION, 2013, 93 : 284A - 284A
  • [10] TUMOUR MARKER HE4 IN PATIENTS WITH OVARIAN CANCER
    Viikant, N.
    Fomichev, M.
    Tehvre, M.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S280 - S280
12345